TreeWAS – Variant ID: rs4236644

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
R40.0 Somnolence	0.032	0.968	0.000
S72.10 Pertrochanteric fracture (closed)	0.032	0.968	0.000
R40 Somnolence, stupor and coma	0.026	0.974	0.000
R40.2 Coma, unspecified	0.025	0.975	0.000
T21 Burn and corrosion of trunk	0.000	0.977	0.023
T20-T25 Burns and corrosions of external body surface, specified by site	0.000	0.977	0.023
T24 Burn and corrosion of hip and lower limb, except ankle and foot	0.000	0.978	0.022
T25 Burn and corrosion of ankle and foot	0.000	0.978	0.022
T20 Burn and corrosion of head and neck	0.000	0.979	0.021
T21.2 Burn of second degree of trunk	0.000	0.979	0.020
T21.0 Burn of unspecified degree of trunk	0.000	0.979	0.020
T24.3 Burn of third degree of hip and lower limb, except ankle and foot	0.000	0.980	0.020
T25.3 Burn of third degree of ankle and foot	0.000	0.980	0.020
R40.1 Stupor	0.020	0.980	0.000
T21.3 Burn of third degree of trunk	0.000	0.981	0.019
T24.2 Burn of second degree of hip and lower limb, except ankle and foot	0.000	0.981	0.019
T21.1 Burn of first degree of trunk	0.000	0.982	0.018
T25.2 Burn of second degree of ankle and foot	0.000	0.982	0.018
T20.0 Burn of unspecified degree of head and neck	0.000	0.982	0.018
T20.3 Burn of third degree of head and neck	0.000	0.982	0.017
T25.0 Burn of unspecified degree of ankle and foot	0.000	0.983	0.017
T21.7 Corrosion of third degree of trunk	0.000	0.983	0.017
T21.6 Corrosion of second degree of trunk	0.000	0.983	0.017
T21.5 Corrosion of first degree of trunk	0.000	0.983	0.017
T21.4 Corrosion of unspecified degree of trunk	0.000	0.983	0.017
T24.0 Burn of unspecified degree of hip and lower limb, except ankle and foot	0.000	0.983	0.017
T20.2 Burn of second degree of head and neck	0.000	0.983	0.017
T23 Burn and corrosion of wrist and hand	0.000	0.983	0.017
T22 Burn and corrosion of shoulder and upper limb, except wrist and hand	0.000	0.984	0.016
T24.7 Corrosion of third degree of hip and lower limb, except ankle and foot	0.000	0.984	0.016
T24.6 Corrosion of second degree of hip and lower limb, except ankle and foot	0.000	0.984	0.016
T24.5 Corrosion of first degree of hip and lower limb, except ankle and foot	0.000	0.984	0.016
T24.4 Corrosion of unspecified degree of hip and lower limb, except ankle and foot	0.000	0.984	0.016
T25.7 Corrosion of third degree of ankle and foot	0.000	0.984	0.016
T25.6 Corrosion of second degree of ankle and foot	0.000	0.984	0.016
T25.5 Corrosion of first degree of ankle and foot	0.000	0.984	0.016
T25.4 Corrosion of unspecified degree of ankle and foot	0.000	0.984	0.016
T25.1 Burn of first degree of ankle and foot	0.000	0.984	0.016
T20.1 Burn of first degree of head and neck	0.000	0.984	0.016
S72.1 Pertrochanteric fracture	0.015	0.984	0.000
T20.7 Corrosion of third degree of head and neck	0.000	0.985	0.015
T20.6 Corrosion of second degree of head and neck	0.000	0.985	0.015
T20.5 Corrosion of first degree of head and neck	0.000	0.985	0.015
T20.4 Corrosion of unspecified degree of head and neck	0.000	0.985	0.015
T24.1 Burn of first degree of hip and lower limb, except ankle and foot	0.000	0.985	0.015
T23.1 Burn of first degree of wrist and hand	0.000	0.987	0.013
T22.3 Burn of third degree of shoulder and upper limb, except wrist and hand	0.000	0.988	0.012
T22.0 Burn of unspecified degree of shoulder and upper limb, except wrist and hand	0.000	0.988	0.012
T23.7 Corrosion of third degree of wrist and hand	0.000	0.988	0.012
T23.6 Corrosion of second degree of wrist and hand	0.000	0.988	0.012
T23.5 Corrosion of first degree of wrist and hand	0.000	0.988	0.012
T23.4 Corrosion of unspecified degree of wrist and hand	0.000	0.988	0.012
T23.0 Burn of unspecified degree of wrist and hand	0.000	0.988	0.012
T22.7 Corrosion of third degree of shoulder and upper limb, except wrist and hand	0.000	0.988	0.012
T22.6 Corrosion of second degree of shoulder and upper limb, except wrist and hand	0.000	0.988	0.012
T22.5 Corrosion of first degree of shoulder and upper limb, except wrist and hand	0.000	0.988	0.012
T22.4 Corrosion of unspecified degree of shoulder and upper limb, except wrist and hand	0.000	0.988	0.012
T22.2 Burn of second degree of shoulder and upper limb, except wrist and hand	0.000	0.988	0.011
T23.3 Burn of third degree of wrist and hand	0.000	0.988	0.011
S72.11 Pertrochanteric fracture (open)	0.011	0.989	0.000
T23.2 Burn of second degree of wrist and hand	0.000	0.989	0.011
T22.1 Burn of first degree of shoulder and upper limb, except wrist and hand	0.000	0.990	0.010
M19.17 Post-traumatic arthrosis of other joints (Ankle and foot)	0.000	0.990	0.010
Z91.6 Personal history of other physical trauma	0.000	0.991	0.009
I42.0 Dilated cardiomyopathy	0.000	0.992	0.008
T39.0 Salicylates	0.008	0.992	0.000
Z50.8 Care involving use of rehabilitation procedures	0.000	0.993	0.007
W07.0 Home	0.000	0.993	0.007
R19.0 Intra-abdominal and pelvic swelling, mass and lump	0.000	0.993	0.007
R17 Unspecified jaundice	0.007	0.993	0.000
I42 Cardiomyopathy	0.000	0.994	0.006
W18.3 Sports and athletics area	0.006	0.994	0.000
T45.5 Anticoagulants	0.006	0.994	0.000
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified	0.006	0.994	0.000
I42.2 Other hypertrophic cardiomyopathy	0.000	0.994	0.006
I42.1 Obstructive hypertrophic cardiomyopathy	0.000	0.994	0.006
H66.9 Otitis media, unspecified	0.006	0.994	0.000
T39 Poisoning by nonopioid analgesics, antipyretics and antirheumatics	0.006	0.994	0.000
I42.5 Other restrictive cardiomyopathy	0.000	0.994	0.005
I42.6 Alcoholic cardiomyopathy	0.000	0.995	0.005
H73.8 Other specified disorders of tympanic membrane	0.005	0.995	0.000
T36-T50 Poisoning by drugs, medicaments and biological substances	0.005	0.995	0.000
K25.7 Chronic without haemorrhage or perforation	0.005	0.995	0.000
H73 Other disorders of tympanic membrane	0.005	0.995	0.000
H74 Other disorders of middle ear and mastoid	0.005	0.995	0.000
I42.7 Cardiomyopathy due to drugs and other external agents	0.000	0.995	0.005
I42.3 Endomyocardial (eosinophilic) disease	0.000	0.995	0.005
H74.9 Disorder of middle ear and mastoid, unspecified	0.005	0.995	0.000
K55.0 Acute vascular disorders of intestine	0.000	0.995	0.005
H74.4 Polyp of middle ear	0.005	0.995	0.000
K55.2 Angiodysplasia of colon	0.000	0.995	0.005
T45.0 Antiallergic and antiemetic drugs	0.005	0.995	0.000
Z49.1 Extracorporeal dialysis	0.005	0.995	0.000
T45.2 Vitamins, not elsewhere classified	0.005	0.995	0.000
I42.8 Other cardiomyopathies	0.000	0.995	0.005
T45.1 Antineoplastic and immunosuppressive drugs	0.005	0.995	0.000
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances	0.005	0.995	0.000
C92.0 Acute myeloid leukaemia	0.005	0.995	0.000
G31.9 Degenerative disease of nervous system, unspecified	0.000	0.995	0.005
T47 Poisoning by agents primarily affecting gastro-intestinal system	0.004	0.995	0.000
H73.9 Disorder of tympanic membrane, unspecified	0.004	0.995	0.000
T36 Poisoning by systemic antibiotics	0.004	0.996	0.000
H74.0 Tympanosclerosis	0.004	0.996	0.000
H66 Suppurative and unspecified otitis media	0.004	0.996	0.000
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.004	0.996	0.000
K55.9 Vascular disorder of intestine, unspecified	0.000	0.996	0.004
T45.9 Primarily systemic and haematological agent, unspecified	0.004	0.996	0.000
T45.8 Other primarily systemic and haematological agents	0.004	0.996	0.000
T45.7 Anticoagulant antagonists, vitamin K and other coagulants	0.004	0.996	0.000
T45.6 Fibrinolysis-affecting drugs	0.004	0.996	0.000
T45.4 Iron and its compounds	0.004	0.996	0.000
T45.3 Enzymes, not elsewhere classified	0.004	0.996	0.000
K55 Vascular disorders of intestine	0.000	0.996	0.004
Z50 Care involving use of rehabilitation procedures	0.000	0.996	0.004
T37 Poisoning by other systemic anti-infectives and antiparasitics	0.004	0.996	0.000
T46 Poisoning by agents primarily affecting the cardiovascular system	0.004	0.996	0.000
I42.4 Endocardial fibroelastosis	0.000	0.996	0.004
T50.9 Other and unspecified drugs, medicaments and biological substances	0.004	0.996	0.000
Z50.7 Occupational therapy and vocational rehabilitation, not elsewhere classified	0.000	0.996	0.004
T39.4 Antirheumatics, not elsewhere classified	0.004	0.996	0.000
T39.2 Pyrazolone derivatives	0.004	0.996	0.000
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs	0.004	0.996	0.000
I42.9 Cardiomyopathy, unspecified	0.000	0.996	0.004
T41 Poisoning by anaesthetics and therapeutic gases	0.004	0.996	0.000
T39.9 Nonopioid analgesic, antipyretic and antirheumatic, unspecified	0.004	0.996	0.000
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]	0.004	0.996	0.000
H73.0 Acute myringitis	0.004	0.996	0.000
Q23.0 Congenital stenosis of aortic valve	0.000	0.996	0.004
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system	0.004	0.996	0.000
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics	0.004	0.996	0.000
H65-H75 Diseases of middle ear and mastoid	0.004	0.996	0.000
T38.8 Other and unspecified hormones and their synthetic substitutes	0.004	0.996	0.000
N90.5 Atrophy of vulva	0.004	0.996	0.000
Z50.4 Psychotherapy, not elsewhere classified	0.000	0.996	0.004
H74.2 Discontinuity and dislocation of ear ossicles	0.004	0.996	0.000
T39.1 4-Aminophenol derivatives	0.004	0.996	0.000
T47.2 Stimulant laxatives	0.004	0.996	0.000
H74.1 Adhesive middle ear disease	0.004	0.996	0.000
Q23.1 Congenital insufficiency of aortic valve	0.000	0.996	0.004
H66.0 Acute suppurative otitis media	0.004	0.996	0.000
Z50.1 Other physical therapy	0.000	0.996	0.004
T36.8 Other systemic antibiotics	0.004	0.996	0.000
Z49 Care involving dialysis	0.004	0.996	0.000
T46.3 Coronary vasodilators, not elsewhere classified	0.004	0.996	0.000
T50.1 Loop [high-ceiling] diuretics	0.004	0.996	0.000
T37.8 Other specified systemic anti-infectives and antiparasitics	0.004	0.996	0.000
T47.4 Other laxatives	0.004	0.996	0.000
H73.1 Chronic myringitis	0.004	0.996	0.000
Z49.2 Other dialysis	0.004	0.996	0.000
H74.8 Other specified disorders of middle ear and mastoid	0.004	0.996	0.000
T40.6 Other and unspecified narcotics	0.004	0.996	0.000
T46.5 Other antihypertensive drugs, not elsewhere classified	0.004	0.996	0.000
Z50.9 Care involving use of rehabilitation procedure, unspecified	0.000	0.996	0.004
T46.2 Other antidysrhythmic drugs, not elsewhere classified	0.004	0.996	0.000
H66.4 Suppurative otitis media, unspecified	0.004	0.996	0.000
T38.0 Glucocorticoids and synthetic analogues	0.004	0.996	0.000
T47.6 Antidiarrhoeal drugs	0.003	0.996	0.000
T36.0 Penicillins	0.004	0.996	0.000
H34.2 Other retinal artery occlusions	0.000	0.996	0.004
T50.7 Analeptics and opioid receptor antagonists	0.003	0.996	0.000
T50.5 Appetite depressants	0.003	0.996	0.000
T50.3 Electrolytic, caloric and water-balance agents	0.003	0.996	0.000
T50.0 Mineralocorticoids and their antagonists	0.003	0.996	0.000
Z49.0 Preparatory care for dialysis	0.004	0.996	0.000
H34.9 Retinal vascular occlusion, unspecified	0.000	0.996	0.004
T38.6 Antigonadotrophins. antioestrogens, antiandrogens, not elsewhere classified	0.003	0.996	0.000
T46.9 Other and unspecified agents primarily affecting the cardiovascular system	0.003	0.996	0.000
T36.4 Tetracyclines	0.003	0.996	0.000
T39.8 Other nonopioid analgesics and antipyretics, not elsewhere classified	0.003	0.996	0.000
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.003	0.996	0.000
T47.8 Other agents primarily affecting the gastro-intestinal system	0.003	0.996	0.000
T47.7 Emetics	0.003	0.996	0.000
T47.5 Digestants	0.003	0.996	0.000
T47.3 Saline and osmotic laxatives	0.003	0.996	0.000
T47.1 Other antacids and anti-gastric-secretion drugs	0.003	0.996	0.000
T49.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified	0.003	0.996	0.000
S72 Fracture of femur	0.003	0.996	0.000
T39.3 Other nonsteroidal anti-inflammatory drugs [NSAID]	0.003	0.996	0.000
M84.07 Malunion of fracture (Ankle and foot)	0.003	0.997	0.000
T36.9 Systemic antibiotic, unspecified	0.003	0.997	0.000
T36.7 Antifungal antibiotics, systemically used	0.003	0.997	0.000
T36.6 Rifamycins	0.003	0.997	0.000
T36.5 Aminoglycosides	0.003	0.997	0.000
T36.2 Chloramphenicol group	0.003	0.997	0.000
T36.1 Cefalosporins and other Beta-lactam antibiotics	0.003	0.997	0.000
T37.2 Antimalarials and drugs acting on other blood protozoa	0.003	0.997	0.000
T38.9 Other and unspecified hormone antagonists	0.003	0.997	0.000
T38.7 Androgens and anabolic congeners	0.003	0.997	0.000
T38.4 Oral contraceptives	0.003	0.997	0.000
T38.2 Antithyroid drugs	0.003	0.997	0.000
T36.3 Macrolides	0.003	0.997	0.000
T46.1 Calcium-channel blockers	0.003	0.997	0.000
T37.9 Systemic anti-infective and antiparasitic, unspecified	0.003	0.997	0.000
T37.5 Antiviral drugs	0.003	0.997	0.000
T37.4 Anthelminthics	0.003	0.997	0.000
T37.3 Other antiprotozoal drugs	0.003	0.997	0.000
T37.1 Antimycobacterial drugs	0.003	0.997	0.000
T37.0 Sulphonamides	0.003	0.997	0.000
Z50.6 Orthoptic training	0.000	0.997	0.003
Q23 Congenital malformations of aortic and mitral valves	0.000	0.997	0.003
T50.4 Drugs affecting uric acid metabolism	0.003	0.997	0.000
T38.1 Thyroid hormones and substitutes	0.003	0.997	0.000
T40.3 Methadone	0.003	0.997	0.000
T46.8 Antivaricose drugs, including sclerosing agents	0.003	0.997	0.000
T46.7 Peripheral vasodilators	0.003	0.997	0.000
T48.5 Anti-common-cold drugs	0.003	0.997	0.000
K55.1 Chronic vascular disorders of intestine	0.000	0.997	0.003
T41.2 Other and unspecified general anaesthetics	0.003	0.997	0.000
T50.6 Antidotes and chelating agents, not elsewhere classified	0.003	0.997	0.000
Z50.3 Drug rehabilitation	0.000	0.997	0.003
L27.0 Generalised skin eruption due to drugs and medicaments	0.000	0.997	0.003
H34 Retinal vascular occlusions	0.000	0.997	0.003
T38.5 Other oestrogens and progestogens	0.003	0.997	0.000
T40.5 Cocaine	0.003	0.997	0.000
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.003	0.997	0.000
T49.9 Topical agent, unspecified	0.003	0.997	0.000
T49.8 Other topical agents	0.003	0.997	0.000
T49.7 Dental drugs, topically applied	0.003	0.997	0.000
T49.6 Otorhinolaryngological drugs and preparations	0.003	0.997	0.000
T49.5 Ophthalmological drugs and preparations	0.003	0.997	0.000
T49.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations	0.003	0.997	0.000
T49.3 Emollients, demulcents and protectants	0.003	0.997	0.000
T49.2 Local astringents and local detergents	0.003	0.997	0.000
T49.1 Antipruritics	0.003	0.997	0.000
H69 Other disorders of Eustachian tube	0.003	0.997	0.000
T47.0 Histamine H(2)-receptor antagonists	0.003	0.997	0.000
T44 Poisoning by drugs primarily affecting the autonomic nervous system	0.003	0.997	0.000
M84.03 Malunion of fracture (Forearm)	0.003	0.997	0.000
H70 Mastoiditis and related conditions	0.003	0.997	0.000
T41.5 Therapeutic gases	0.003	0.997	0.000
T41.4 Anaesthetic, unspecified	0.003	0.997	0.000
T41.3 Local anaesthetics	0.003	0.997	0.000
T41.1 Intravenous anaesthetics	0.003	0.997	0.000
T41.0 Inhaled anaesthetics	0.003	0.997	0.000
T40.9 Other and unspecified psychodysleptics [hallucinogens]	0.003	0.997	0.000
T40.8 Lysergide [LSD]	0.003	0.997	0.000
T40.7 Cannabis (derivatives)	0.003	0.997	0.000
T40.0 Opium	0.003	0.997	0.000
T48.7 Other and unspecified agents primarily acting on the respiratory system	0.003	0.997	0.000
T48.4 Expectorants	0.003	0.997	0.000
T48.3 Antitussives	0.003	0.997	0.000
T48.2 Other and unspecified agents primarily acting on muscles	0.003	0.997	0.000
T48.1 Skeletal muscle relaxants [neuromuscular blocking agents]	0.003	0.997	0.000
T48.0 Oxytocic drugs	0.003	0.997	0.000
Z50.0 Cardiac rehabilitation	0.000	0.997	0.003
H75 Other disorders of middle ear and mastoid in diseases classified elsewhere	0.003	0.997	0.000
H67 Otitis media in diseases classified elsewhere	0.003	0.997	0.000
S62.61 Fracture of other finger (open)	0.000	0.997	0.003
T40.1 Heroin	0.003	0.997	0.000
H68 Eustachian salpingitis and obstruction	0.003	0.997	0.000
T43 Poisoning by psychotropic drugs, not elsewhere classified	0.003	0.997	0.000
H72.9 Perforation of tympanic membrane, unspecified	0.003	0.997	0.000
K55.8 Other vascular disorders of intestine	0.000	0.997	0.003
T48.6 Antiasthmatics, not elsewhere classified	0.003	0.997	0.000
H66.3 Other chronic suppurative otitis media	0.003	0.997	0.000
H74.3 Other acquired abnormalities of ear ossicles	0.003	0.997	0.000
C92 Myeloid leukaemia	0.003	0.997	0.000
H34.1 Central retinal artery occlusion	0.000	0.997	0.003
S72.3 Fracture of shaft of femur	0.003	0.997	0.000
T50.8 Diagnostic agents	0.003	0.997	0.000
H34.8 Other retinal vascular occlusions	0.000	0.997	0.003
T38.3 Insulin and oral hypoglycaemic [antidiabetic] drugs	0.003	0.997	0.000
C91.0 Acute lymphoblastic leukaemia	0.003	0.997	0.000
T40.2 Other opioids	0.003	0.997	0.000
M84.0 Malunion of fracture	0.003	0.997	0.000
S72.7 Multiple fractures of femur	0.003	0.997	0.000
H66.1 Chronic tubotympanic suppurative otitis media	0.003	0.997	0.000
H66.2 Chronic atticoantral suppurative otitis media	0.003	0.997	0.000
H70.1 Chronic mastoiditis	0.003	0.997	0.000
S72.30 Fracture of shaft of femur (closed)	0.003	0.997	0.000
T46.0 Cardiac-stimulant glycosides and drugs of similar action	0.003	0.997	0.000
H69.9 Eustachian tube disorder, unspecified	0.003	0.997	0.000
C07 Malignant neoplasm of parotid gland	0.003	0.997	0.000
S72.9 Fracture of femur, part unspecified	0.003	0.997	0.000
M84.02 Malunion of fracture (Upper arm)	0.003	0.997	0.000
S72.8 Fractures of other parts of femur	0.003	0.997	0.000
T43.0 Tricyclic and tetracyclic antidepressants	0.003	0.997	0.000
H72 Perforation of tympanic membrane	0.003	0.997	0.000
T43.4 Butyrophenone and thioxanthene neuroleptics	0.003	0.997	0.000
Z71.8 Other specified counselling	0.000	0.997	0.003
H70.8 Other mastoiditis and related conditions	0.003	0.997	0.000
Q23.9 Congenital malformation of aortic and mitral valves, unspecified	0.000	0.997	0.003
Q23.8 Other congenital malformations of aortic and mitral valves	0.000	0.997	0.003
Q23.4 Hypoplastic left heart syndrome	0.000	0.997	0.003
Q23.2 Congenital mitral stenosis	0.000	0.997	0.003
C92.4 Acute promyelocytic leukaemia	0.003	0.997	0.000
C92.1 Chronic myeloid leukaemia	0.003	0.997	0.000
R41.3 Other amnesia	0.003	0.997	0.000
T43.5 Other and unspecified antipsychotics and neuroleptics	0.003	0.997	0.000
T44.9 Other and unspecified drugs primarily affecting the nervous system	0.003	0.997	0.000
W18 Other fall on same level	0.002	0.997	0.000
H34.0 Transient retinal artery occlusion	0.000	0.997	0.003
Q23.3 Congenital mitral insufficiency	0.000	0.997	0.003
R73.0 Abnormal glucose tolerance test	0.003	0.997	0.000
H69.0 Patulous Eustachian tube	0.002	0.997	0.000
H70.2 Petrositis	0.002	0.997	0.000
M19.1 Posttraumatic arthrosis of other joints	0.000	0.997	0.003
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified	0.002	0.997	0.000
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.002	0.997	0.000
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.002	0.997	0.000
T44.2 Ganglionic blocking drugs, not elsewhere classified	0.002	0.997	0.000
T44.1 Other parasympathomimetics [cholinergics]	0.002	0.997	0.000
T44.0 Anticholinesterase agents	0.002	0.997	0.000
Z86.1 Personal history of infectious and parasitic diseases	0.000	0.997	0.003
H70.9 Mastoiditis, unspecified	0.002	0.997	0.000
T43.9 Psychotropic drug, unspecified	0.003	0.997	0.000
T43.6 Psychostimulants with abuse potential	0.003	0.997	0.000
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified	0.002	0.997	0.000
H67.8 Otitis media in other diseases classified elsewhere	0.002	0.997	0.000
H67.1 Otitis media in viral diseases classified elsewhere	0.002	0.997	0.000
H67.0 Otitis media in bacterial diseases classified elsewhere	0.002	0.997	0.000
H75.8 Other specified disorders of middle ear and mastoid in diseases classified elsewhere	0.002	0.997	0.000
H75.0 Mastoiditis in infectious and parasitic diseases classified elsewhere	0.002	0.997	0.000
T46.4 Angiotensin-converting-enzyme inhibitors	0.002	0.997	0.000
S72.70 Multiple fractures of femur (closed)	0.002	0.997	0.000
M84.08 Malunion of fracture (Other)	0.002	0.997	0.000
H68.0 Eustachian salpingitis	0.002	0.997	0.000
N90.7 Vulvar cyst	0.003	0.997	0.000
T43.8 Other psychotropic drugs, not elsewhere classified	0.002	0.997	0.000
M84.05 Malunion of fracture (Pelvic region and thigh)	0.002	0.997	0.000
T40.4 Other synthetic narcotics	0.002	0.997	0.000
C92.8 Acute myeloid leukaemia with multilineage dysplasia	0.002	0.997	0.000
C92.6 Acute myeloid leukaemia with 11q23-abnormality	0.002	0.997	0.000
C92.3 Myeloid sarcoma	0.002	0.997	0.000
C92.2 Subacute myeloid leukaemia	0.002	0.997	0.000
H68.1 Obstruction of Eustachian tube	0.002	0.998	0.000
H69.8 Other specified disorders of Eustachian tube	0.002	0.998	0.000
G55.3 Nerve root and plexus compressions in other dorsopathies	0.000	0.998	0.002
N97.9 Female infertility, unspecified	0.002	0.998	0.000
Z50.2 Alcohol rehabilitation	0.000	0.998	0.002
M84.09 Malunion of fracture (Site unspecified)	0.002	0.998	0.000
M84.00 Malunion of fracture (Multiple sites)	0.002	0.998	0.000
W07 Fall involving chair	0.000	0.998	0.002
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified	0.002	0.998	0.000
S72.71 Multiple fractures of femur (open)	0.002	0.998	0.000
M84.06 Malunion of fracture (Lower leg)	0.002	0.998	0.000
M07.30 Other psoriatic arthropathies (Multiple sites)	0.002	0.998	0.000
C92.5 Acute myelomonocytic leukaemia	0.002	0.998	0.000
H72.1 Attic perforation of tympanic membrane	0.002	0.998	0.000
M84.01 Malunion of fracture (Shoulder region)	0.002	0.998	0.000
S72.90 Fracture of femur, part unspecified (closed)	0.002	0.998	0.000
R73.9 Hyperglycaemia, unspecified	0.002	0.998	0.000
T43.1 Monoamine-oxidase-inhibitor antidepressants	0.002	0.998	0.000
S72.91 Fracture of femur, part unspecified (open)	0.002	0.998	0.000
S72.31 Fracture of shaft of femur (open)	0.002	0.998	0.000
S72.81 Fractures of other parts of femur (open)	0.002	0.998	0.000
C85.1 B-cell lymphoma, unspecified	0.002	0.998	0.000
C92.9 Myeloid leukaemia, unspecified	0.002	0.998	0.000
S72.2 Subtrochanteric fracture	0.002	0.998	0.000
S72.80 Fractures of other parts of femur (closed)	0.002	0.998	0.000
G57.8 Other mononeuropathies of lower limb	0.000	0.998	0.002
W18.5 Trade and service area	0.002	0.998	0.000
Y51.7 Beta-Adrenoreceptor antagonists, not elsewhere classified	0.002	0.998	0.000
Z41.1 Other plastic surgery for unacceptable cosmetic appearance	0.000	0.998	0.002
K29.1 Other acute gastritis	0.002	0.998	0.000
H49.0 Third [oculomotor] nerve palsy	0.000	0.998	0.002
W18.9 Unspecified place	0.002	0.998	0.000
W18.8 Other specified place	0.002	0.998	0.000
W18.4 Street and highway	0.002	0.998	0.000
W18.2 School, other institution and public administrative area	0.002	0.998	0.000
W18.0 Home	0.002	0.998	0.000
W18.7 Farm	0.002	0.998	0.000
C91 Lymphoid leukaemia	0.002	0.998	0.000
C92.7 Other myeloid leukaemia	0.002	0.998	0.000
Z87.7 Personal history of congenital malformations, deformations and chromosomal abnormalities	0.000	0.998	0.002
G31 Other degenerative diseases of nervous system, not elsewhere classified	0.000	0.998	0.002
H70.0 Acute mastoiditis	0.002	0.998	0.000
W18.6 Industrial and construction area	0.002	0.998	0.000
M19.19 Post-traumatic arthrosis of other joints (Site unspecified)	0.000	0.998	0.002
M19.18 Post-traumatic arthrosis of other joints (Other)	0.000	0.998	0.002
M19.16 Post-traumatic arthrosis of other joints-Lower leg	0.000	0.998	0.002
M19.15 Post-traumatic arthrosis of other joints (Pelvic region and thigh)	0.000	0.998	0.002
M19.10 Post-traumatic arthrosis of other joints (Multiple sites)	0.000	0.998	0.002
Z50.5 Speech therapy	0.000	0.998	0.002
D12.7 Rectosigmoid junction	0.002	0.998	0.000
N90.4 Leukoplakia of vulva	0.002	0.998	0.000
W07.5 Trade and service area	0.000	0.998	0.002
M19.12 Post-traumatic arthrosis of other joints (Upper arm)	0.000	0.998	0.002
G31.0 Circumscribed brain atrophy	0.000	0.998	0.002
C91.5 Adult T-cell leukaemia	0.002	0.998	0.000
W07.1 Residential institution	0.000	0.998	0.002
S82.30 Fracture of lower end of tibia (closed)	0.002	0.998	0.000
W10.8 Other specified place	0.000	0.998	0.002
W18.1 Residential institution	0.002	0.998	0.000
M19.11 Post-traumatic arthrosis of other joints (Shoulder region)	0.000	0.998	0.002
T44.7 Beta-Adrenoreceeptor antagonists, not elsewhere classified	0.002	0.998	0.000
W07.2 School, other institution and public administrative area	0.000	0.998	0.002
W07.7 Farm	0.000	0.998	0.002
W07.6 Industrial and construction area	0.000	0.998	0.002
W07.4 Street and highway	0.000	0.998	0.002
W07.3 Sports and athletics area	0.000	0.998	0.002
R73 Elevated blood glucose level	0.002	0.998	0.000
G31.2 Degeneration of nervous system due to alcohol	0.000	0.998	0.002
C81-C96 Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue	0.002	0.998	0.000
M19.13 Post-traumatic arthrosis of other joints (Forearm)	0.000	0.998	0.002
R46.4 Slowness and poor responsiveness	0.002	0.998	0.000
C85 Other and unspecified types of non-Hodgkin's lymphoma	0.002	0.998	0.000
S68.1 Traumatic amputation of other single finger (complete)(partial)	0.002	0.998	0.000
S72.21 Subtrochanteric fracture (open)	0.002	0.998	0.000
M84.04 Malunion of fracture (Hand)	0.002	0.998	0.000
S72.4 Fracture of lower end of femur	0.002	0.998	0.000
C91.8 Mature B-cell leukaemia Burkitt-type	0.002	0.998	0.000
C91.7 Other lymphoid leukaemia	0.002	0.998	0.000
C91.6 Prolymphocytic leukaemia of T-cell type	0.002	0.998	0.000
C91.3 Prolymphocytic leukaemia	0.002	0.998	0.000
C91.2 Subacute lymphocytic leukaemia	0.002	0.998	0.000
I70.20 Atherosclerosis of arteries of extremities (without gangrene)	0.002	0.998	0.000
W18.09 Other fall on same level: Home: During unspecified activity	0.001	0.998	0.000
W18.04 Other fall on same level, Home , While resting, sleeping, eating or engaging in other vital activities	0.001	0.998	0.000
W18.22 Other fall on same level; School, other institution and public administrative area; While working for income	0.001	0.998	0.000
W18.49 Other fall on same level; Street and highway; During unspecified activity	0.001	0.998	0.000
W18.48 Other fall on same level; Street and highway; While engaged in other specified activities	0.001	0.998	0.000
W18.89 Other fall on same level; Other specified places; During unspecified activity	0.001	0.998	0.000
W18.99 Other fall on same level; Unspecified place; During unspecified activity	0.001	0.998	0.000
W18.93 Other fall on same level; Unspecified place; While engaged in other types of work	0.001	0.998	0.000
G31.1 Senile degeneration of brain, not elsewhere classified	0.000	0.998	0.002
H65 Nonsuppurative otitis media	0.002	0.998	0.000
M47.87 Other spondylosis (Lumbosacral region)	0.002	0.998	0.000
W07.8 Other specified place	0.000	0.998	0.002
C95 Leukaemia of unspecified cell type	0.002	0.998	0.000
M19.14 Post-traumatic arthrosis of other joints (Hand)	0.000	0.998	0.002
C83.8 Other types of diffuse non-Hodgkin's lymphoma	0.002	0.998	0.000
N90 Other noninflammatory disorders of vulva and perineum	0.002	0.998	0.000
C95.0 Acute leukaemia of unspecified cell type	0.002	0.998	0.000
N13.5 Kinking and stricture of ureter without hydronephrosis	0.002	0.998	0.000
H71 Cholesteatoma of middle ear	0.002	0.998	0.000
C83.7 Burkitt's tumour	0.002	0.998	0.000
C85.7 Other specified types of non-Hodgkin's lymphoma	0.002	0.998	0.000
C88 Malignant immunoproliferative diseases	0.002	0.998	0.000
R46.2 Strange and inexplicable behaviour	0.002	0.998	0.000
C83 Diffuse non-Hodgkin's lymphoma	0.002	0.998	0.000
R46 Symptoms and signs involving appearance and behaviour	0.002	0.998	0.000
M90.75 Fracture of bone in neoplastic disease (Pelvic region and thigh)	0.002	0.998	0.000
H65.0 Acute serous otitis media	0.002	0.998	0.000
H72.2 Other marginal perforations of tympanic membrane	0.001	0.998	0.000
C94 Other leukaemias of specified cell type	0.002	0.998	0.000
W07.29 Fall involving chair; School, other institution and public administrative area; During unspecified activity	0.000	0.998	0.001
C83.3 Large cell (diffuse)	0.002	0.998	0.000
C85.0 Lymphosarcoma	0.002	0.998	0.000
H72.8 Other perforations of tympanic membrane	0.002	0.998	0.000
M20.6 Acquired deformity of toe(s), unspecified	0.002	0.998	0.000
Z71.9 Counselling, unspecified	0.002	0.998	0.000
C09.9 Tonsil, unspecified	0.002	0.998	0.000
H65.2 Chronic serous otitis media	0.002	0.998	0.000
S68.0 Traumatic amputation of thumb (complete)(partial)	0.002	0.998	0.000
C91.4 Hairy-cell leukaemia	0.002	0.998	0.000
J34.3 Hypertrophy of nasal turbinates	0.000	0.998	0.002
N90.3 Dysplasia of vulva, unspecified	0.002	0.998	0.000
S72.0 Fracture of neck of femur	0.002	0.998	0.000
C96 Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue	0.002	0.998	0.000
C83.5 Lymphoblastic (diffuse)	0.002	0.998	0.000
C86 Other specified types of T/NK-cell lymphoma	0.002	0.998	0.000
C84 Peripheral and cutaneous T-cell lymphomas	0.002	0.998	0.000
C88.4 Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue [MALT-lymphoma]	0.001	0.998	0.000
S40.0 Contusion of shoulder and upper arm	0.002	0.998	0.000
C95.9 Leukaemia, unspecified	0.001	0.998	0.000
G31.8 Other specified degenerative diseases of nervous system	0.001	0.998	0.000
C16.5 Lesser curvature of stomach, unspecified	0.002	0.998	0.000
C77.5 Intrapelvic lymph nodes	0.002	0.998	0.000
C91.9 Lymphoid leukaemia, unspecified	0.001	0.998	0.000
C95.7 Other leukaemia of unspecified cell type	0.001	0.998	0.000
C95.2 Subacute leukaemia of unspecified cell type	0.001	0.998	0.000
S76.4 Injury of other and unspecified muscles and tendons at thigh level	0.002	0.998	0.000
C09 Malignant neoplasm of tonsil	0.002	0.998	0.000
C84.4 Peripheral T-cell lymphoma	0.001	0.998	0.000
C88.0 Waldenstrom's macroglobulinaemia	0.001	0.998	0.000
C94.4 Acute panmyelosis	0.001	0.998	0.000
N90.2 Severe vulvar dysplasia, not elsewhere classified	0.001	0.998	0.000
C83.6 Undifferentiated (diffuse)	0.001	0.998	0.000
C83.4 Immunoblastic (diffuse)	0.001	0.998	0.000
C83.2 Mixed small and large cell (diffuse)	0.001	0.998	0.000
C88.9 Malignant immunoproliferative disease, unspecified	0.001	0.998	0.000
C88.7 Other malignant immunoproliferative diseases	0.001	0.998	0.000
C88.3 Immunoproliferative small intestinal disease	0.001	0.998	0.000
C88.2 Gamma heavy chain disease	0.001	0.998	0.000
C88.1 Alpha heavy chain disease	0.001	0.998	0.000
H65.1 Other acute nonsuppurative otitis media	0.001	0.998	0.000
M19.92 Arthrosis, unspecified (Upper arm)	0.000	0.998	0.002
J93.1 Other spontaneous pneumothorax	0.000	0.998	0.002
S00.3 Superficial injury of nose	0.002	0.998	0.000
C93 Monocytic leukaemia	0.001	0.998	0.000
M07.37 Other psoriatic arthropathies (Ankle and foot)	0.001	0.998	0.000
C84.5 Other and unspecified T-cell lymphomas	0.001	0.998	0.000
C85.2 Mediastinal (thymic) large B-cell lymphoma	0.001	0.998	0.000
C94.7 Other specified leukaemias	0.001	0.998	0.000
C94.5 Acute myelofibrosis	0.001	0.998	0.000
C94.3 Mast cell leukaemia	0.001	0.998	0.000
C94.2 Acute megakaryoblastic leukaemia	0.001	0.998	0.000
C94.1 Chronic erythraemia	0.001	0.998	0.000
C94.0 Acute erythraemia and erythroleukaemia	0.001	0.998	0.000
R46.7 Verbosity and circumstantial detail obscuring reason for contact	0.001	0.998	0.000
R46.6 Undue concern and preoccupation with stressful events	0.001	0.998	0.000
R46.5 Suspiciousness and marked evasiveness	0.001	0.998	0.000
R46.3 Overactivity	0.001	0.998	0.000
R46.1 Bizarre personal appearance	0.001	0.998	0.000
T43.3 Phenothiazine antipsychotics and neuroleptics	0.001	0.998	0.000
M05.90 Seropositive rheumatoid arthritis, unspecified (Multiple sites)	0.002	0.998	0.000
C91.1 Chronic lymphocytic leukaemia	0.002	0.998	0.000
C94.6 Myelodysplastic and myeloproliferative disease, not elsewhere classified	0.001	0.998	0.000
K10.2 Inflammatory conditions of jaws	0.001	0.998	0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations